TY - JOUR
AU - A. DeLisle
AU - H. E. Jones
AU - L. M. Jansson
A1 - 
AD - From the UNC Horizons Program, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC (AD); UNC Horizons Program, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD (HEJ); and Center for Addiction and Pregnancy, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, MD (LMJ).
AN - 36069804
BT - J Addict Med
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 2
DA - Mar-Apr 01
DO - 10.1097/adm.0000000000001065
DP - NLM
ET - 20220906
IS - 2
JF - J Addict Med
LA - eng
PY - 2023
SN - 1932-0620
SP - 123
EP - 125+
ST - Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions
T1 - Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions
T2 - J Addict Med
TI - Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1097/adm.0000000000001065
VL - 17
VO - 1932-0620
Y1 - 2023
ER -